Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery
In recent years, lipid nanoparticles (LNPs) have gained considerable attention in numerous research fields ranging from gene therapy to cancer immunotherapy and DNA vaccination. While some RNA-encapsulating LNP formulations passed clinical trials, DNA-loaded LNPs have been only marginally explored s...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/8/1292 |
id |
doaj-a4bdbd952b574c60976f3fdea73c3bc7 |
---|---|
record_format |
Article |
spelling |
doaj-a4bdbd952b574c60976f3fdea73c3bc72021-08-26T14:13:21ZengMDPI AGPharmaceutics1999-49232021-08-01131292129210.3390/pharmaceutics13081292Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene DeliveryErica Quagliarini0Serena Renzi1Luca Digiacomo2Francesca Giulimondi3Barbara Sartori4Heinz Amenitsch5Valentina Tassinari6Laura Masuelli7Roberto Bei8Lishan Cui9Junbiao Wang10Augusto Amici11Cristina Marchini12Daniela Pozzi13Giulio Caracciolo14Department of Chemistry, “Sapienza” University of Rome, 00185 Rome, ItalyDepartment of Molecular Medicine, “Sapienza” University of Rome, 00161 Rome, ItalyDepartment of Molecular Medicine, “Sapienza” University of Rome, 00161 Rome, ItalyDepartment of Molecular Medicine, “Sapienza” University of Rome, 00161 Rome, ItalyInstitute of inorganic Chemistry, Graz University of Technology, 8010 Graz, AustriaInstitute of inorganic Chemistry, Graz University of Technology, 8010 Graz, AustriaDepartment of Molecular Medicine, “Sapienza” University of Rome, 00161 Rome, ItalyDepartment of Experimental Medicine, “Sapienza” University of Rome, 00185 Rome, ItalyDepartment of Clinical Sciences and Translational Medicine, University of Rome “Tor Vergata”, 00133 Rome, ItalySchool of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, ItalySchool of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, ItalySchool of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, ItalySchool of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, ItalyDepartment of Molecular Medicine, “Sapienza” University of Rome, 00161 Rome, ItalyDepartment of Molecular Medicine, “Sapienza” University of Rome, 00161 Rome, ItalyIn recent years, lipid nanoparticles (LNPs) have gained considerable attention in numerous research fields ranging from gene therapy to cancer immunotherapy and DNA vaccination. While some RNA-encapsulating LNP formulations passed clinical trials, DNA-loaded LNPs have been only marginally explored so far. To fulfil this gap, herein we investigated the effect of several factors influencing the microfluidic formulation and transfection behavior of DNA-loaded LNPs such as PEGylation, total flow rate (TFR), concentration and particle density at the cell surface. We show that PEGylation and post-synthesis sample concentration facilitated formulation of homogeneous and small size LNPs with high transfection efficiency and minor, if any, cytotoxicity on human Embryonic Kidney293 (HEK-293), spontaneously immortalized human keratinocytes (HaCaT), immortalized keratinocytes (N/TERT) generated from the transduction of human primary keratinocytes, and epidermoid cervical cancer (CaSki) cell lines. On the other side, increasing TFR had a detrimental effect both on the physicochemical properties and transfection properties of LNPs. Lastly, the effect of particle concentration at the cell surface on the transfection efficiency (TE) and cell viability was largely dependent on the cell line, suggesting that its case-by-case optimization would be necessary. Overall, we demonstrate that fine tuning formulation and microfluidic parameters is a vital step for the generation of highly efficient DNA-loaded LNPs.https://www.mdpi.com/1999-4923/13/8/1292lipid nanoparticlesmicrofluidicstransfection efficiencylipofectamine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Erica Quagliarini Serena Renzi Luca Digiacomo Francesca Giulimondi Barbara Sartori Heinz Amenitsch Valentina Tassinari Laura Masuelli Roberto Bei Lishan Cui Junbiao Wang Augusto Amici Cristina Marchini Daniela Pozzi Giulio Caracciolo |
spellingShingle |
Erica Quagliarini Serena Renzi Luca Digiacomo Francesca Giulimondi Barbara Sartori Heinz Amenitsch Valentina Tassinari Laura Masuelli Roberto Bei Lishan Cui Junbiao Wang Augusto Amici Cristina Marchini Daniela Pozzi Giulio Caracciolo Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery Pharmaceutics lipid nanoparticles microfluidics transfection efficiency lipofectamine |
author_facet |
Erica Quagliarini Serena Renzi Luca Digiacomo Francesca Giulimondi Barbara Sartori Heinz Amenitsch Valentina Tassinari Laura Masuelli Roberto Bei Lishan Cui Junbiao Wang Augusto Amici Cristina Marchini Daniela Pozzi Giulio Caracciolo |
author_sort |
Erica Quagliarini |
title |
Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery |
title_short |
Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery |
title_full |
Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery |
title_fullStr |
Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery |
title_full_unstemmed |
Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery |
title_sort |
microfluidic formulation of dna-loaded multicomponent lipid nanoparticles for gene delivery |
publisher |
MDPI AG |
series |
Pharmaceutics |
issn |
1999-4923 |
publishDate |
2021-08-01 |
description |
In recent years, lipid nanoparticles (LNPs) have gained considerable attention in numerous research fields ranging from gene therapy to cancer immunotherapy and DNA vaccination. While some RNA-encapsulating LNP formulations passed clinical trials, DNA-loaded LNPs have been only marginally explored so far. To fulfil this gap, herein we investigated the effect of several factors influencing the microfluidic formulation and transfection behavior of DNA-loaded LNPs such as PEGylation, total flow rate (TFR), concentration and particle density at the cell surface. We show that PEGylation and post-synthesis sample concentration facilitated formulation of homogeneous and small size LNPs with high transfection efficiency and minor, if any, cytotoxicity on human Embryonic Kidney293 (HEK-293), spontaneously immortalized human keratinocytes (HaCaT), immortalized keratinocytes (N/TERT) generated from the transduction of human primary keratinocytes, and epidermoid cervical cancer (CaSki) cell lines. On the other side, increasing TFR had a detrimental effect both on the physicochemical properties and transfection properties of LNPs. Lastly, the effect of particle concentration at the cell surface on the transfection efficiency (TE) and cell viability was largely dependent on the cell line, suggesting that its case-by-case optimization would be necessary. Overall, we demonstrate that fine tuning formulation and microfluidic parameters is a vital step for the generation of highly efficient DNA-loaded LNPs. |
topic |
lipid nanoparticles microfluidics transfection efficiency lipofectamine |
url |
https://www.mdpi.com/1999-4923/13/8/1292 |
work_keys_str_mv |
AT ericaquagliarini microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery AT serenarenzi microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery AT lucadigiacomo microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery AT francescagiulimondi microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery AT barbarasartori microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery AT heinzamenitsch microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery AT valentinatassinari microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery AT lauramasuelli microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery AT robertobei microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery AT lishancui microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery AT junbiaowang microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery AT augustoamici microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery AT cristinamarchini microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery AT danielapozzi microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery AT giuliocaracciolo microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery |
_version_ |
1721190689458356224 |